DRAK2 Antibodies

Santa Cruz Biotechnology provides a broad selection of DRAK2 monoclonal antibodies for research focused on understanding DRAK2's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DRAK2, or Death-associated protein kinase 2, is a serine/threonine kinase that plays a crucial role in regulating apoptosis and cell proliferation. DRAK2 participates in various signaling pathways that influence immune responses and cellular stress. Research has shown DRAK2's involvement in multiple biological processes, from immune system regulation to cell death pathways. Understanding DRAK2 function is essential for elucidating its potential implications in cancer and other diseases. Ongoing studies continue to reveal new aspects of DRAK2's biological significance and therapeutic potential. Current investigations are expanding knowledge about DRAK2's role in different tissue types and disease states. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of DRAK2's impact on human health and disease mechanisms.